Cargando…
Antitumor Research on Artemisinin and Its Bioactive Derivatives
ABSTRACT: Cancer is the leading cause of human death which seriously threatens human life. The antimalarial drug artemisinin and its derivatives have been discovered with considerable anticancer properties. Simultaneously, a variety of target-selective artemisinin-related compounds with high efficie...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Singapore
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6102173/ https://www.ncbi.nlm.nih.gov/pubmed/29633188 http://dx.doi.org/10.1007/s13659-018-0162-1 |
_version_ | 1783349104260153344 |
---|---|
author | Zhang, Yunqin Xu, Guowei Zhang, Shuqun Wang, Dong Saravana Prabha, P. Zuo, Zhili |
author_facet | Zhang, Yunqin Xu, Guowei Zhang, Shuqun Wang, Dong Saravana Prabha, P. Zuo, Zhili |
author_sort | Zhang, Yunqin |
collection | PubMed |
description | ABSTRACT: Cancer is the leading cause of human death which seriously threatens human life. The antimalarial drug artemisinin and its derivatives have been discovered with considerable anticancer properties. Simultaneously, a variety of target-selective artemisinin-related compounds with high efficiency have been discovered. Many researches indicated that artemisinin-related compounds have cytotoxic effects against a variety of cancer cells through pleiotropic effects, including inhibiting the proliferation of tumor cells, promoting apoptosis, inducing cell cycle arrest, disrupting cancer invasion and metastasis, preventing angiogenesis, mediating the tumor-related signaling pathways, and regulating tumor microenvironment. More importantly, artemisinins demonstrated minor side effects to normal cells and manifested the ability to overcome multidrug-resistance which is widely observed in cancer patients. Therefore, we concentrated on the new advances and development of artemisinin and its derivatives as potential antitumor agents in recent 5 years. It is our hope that this review could be helpful for further exploration of novel artemisinin-related antitumor agents. GRAPHICAL ABSTRACT: [Image: see text] |
format | Online Article Text |
id | pubmed-6102173 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Springer Singapore |
record_format | MEDLINE/PubMed |
spelling | pubmed-61021732018-08-27 Antitumor Research on Artemisinin and Its Bioactive Derivatives Zhang, Yunqin Xu, Guowei Zhang, Shuqun Wang, Dong Saravana Prabha, P. Zuo, Zhili Nat Prod Bioprospect Review ABSTRACT: Cancer is the leading cause of human death which seriously threatens human life. The antimalarial drug artemisinin and its derivatives have been discovered with considerable anticancer properties. Simultaneously, a variety of target-selective artemisinin-related compounds with high efficiency have been discovered. Many researches indicated that artemisinin-related compounds have cytotoxic effects against a variety of cancer cells through pleiotropic effects, including inhibiting the proliferation of tumor cells, promoting apoptosis, inducing cell cycle arrest, disrupting cancer invasion and metastasis, preventing angiogenesis, mediating the tumor-related signaling pathways, and regulating tumor microenvironment. More importantly, artemisinins demonstrated minor side effects to normal cells and manifested the ability to overcome multidrug-resistance which is widely observed in cancer patients. Therefore, we concentrated on the new advances and development of artemisinin and its derivatives as potential antitumor agents in recent 5 years. It is our hope that this review could be helpful for further exploration of novel artemisinin-related antitumor agents. GRAPHICAL ABSTRACT: [Image: see text] Springer Singapore 2018-04-09 /pmc/articles/PMC6102173/ /pubmed/29633188 http://dx.doi.org/10.1007/s13659-018-0162-1 Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Review Zhang, Yunqin Xu, Guowei Zhang, Shuqun Wang, Dong Saravana Prabha, P. Zuo, Zhili Antitumor Research on Artemisinin and Its Bioactive Derivatives |
title | Antitumor Research on Artemisinin and Its Bioactive Derivatives |
title_full | Antitumor Research on Artemisinin and Its Bioactive Derivatives |
title_fullStr | Antitumor Research on Artemisinin and Its Bioactive Derivatives |
title_full_unstemmed | Antitumor Research on Artemisinin and Its Bioactive Derivatives |
title_short | Antitumor Research on Artemisinin and Its Bioactive Derivatives |
title_sort | antitumor research on artemisinin and its bioactive derivatives |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6102173/ https://www.ncbi.nlm.nih.gov/pubmed/29633188 http://dx.doi.org/10.1007/s13659-018-0162-1 |
work_keys_str_mv | AT zhangyunqin antitumorresearchonartemisininanditsbioactivederivatives AT xuguowei antitumorresearchonartemisininanditsbioactivederivatives AT zhangshuqun antitumorresearchonartemisininanditsbioactivederivatives AT wangdong antitumorresearchonartemisininanditsbioactivederivatives AT saravanaprabhap antitumorresearchonartemisininanditsbioactivederivatives AT zuozhili antitumorresearchonartemisininanditsbioactivederivatives |